Improvement of obsessive-compulsive disorder with divalproex and lamotrigine in two patients with bipolar II disorder

Pharmacopsychiatry

Volumn 42, Issue 1, 2009, Pages 37-39

  Bisol, L W ^a   Lara, D R ^b  

^a Instituto de Ciencias Biologicas e da Saude Pontifical Catholic University of Minas Gerais   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; LAMOTRIGINE; MOOD STABILIZER; PAROXETINE; VALPROATE SEMISODIUM; ANTICONVULSIVE AGENT; TRIAZINE DERIVATIVE; VALPROIC ACID;

ADULT; ALCOHOL ABUSE; BIPOLAR II DISORDER; CASE REPORT; COMORBIDITY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPOMANIA; LETTER; MALE; MANIA; OBSESSIVE COMPULSIVE DISORDER; PANIC; PRIORITY JOURNAL; BIPOLAR DISORDER;

ADULT; ANTICONVULSANTS; BIPOLAR DISORDER; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; TRIAZINES; VALPROIC ACID;

EID: 64749087211     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0028-1085439     Document Type: Letter

References (17)

1. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Aff ect Disord 1998 ; 50 : 143-151
2. Angst J , Gamma A , Endrass J et al. Obsessive-compulsive syndromes and disorders: signifi cance of comorbidity with bipolar and anxiety syndromes. Eur Arch Psy Clin Neurosci 2005 ; 255 : 65-71
3. Bloch MH , Landeros-Weisenberger A , Kelmendi B et al. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiat 2006 ; 11 : 622-632
4. Corá-Locatelli G , Greenberg BD , Martin JD et al. Valproate monotherapy in an SRI-intolerant patient. J Clin Psychiat 1998 ; 59 : 82
5. Dell'Osso B , Altamura AC , Mundo E et al. Diagnosis and treatment of obsessive-compulsive disorder and related disorders. Int J Clin Pract 2007 ; 61 : 98-104
6. Hantouche EG , Angst J , Demonfaucon C et al. Cyclothymic OCD: a distinct form? J Aff ect Disord 2003 ; 75 : 1-10
7. Hollander E , Dell ' Osso B. Topiramate plus paroxetine in treatmentresistant obsessive-compulsive disorder. Int Clin Psychopharmacol 2006 ; 21 : 189-191
8. Kumar TC , Khanna S. Lamotrigine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder. Aust N Z J Psychiat 2000 ; 34 : 527-528
9. Lara DR , Pinto O , Akiskal K et al. Toward an integrative model of the spectrum of mood, behavioral and personality disorders base don fear and anger traits: I. Clinical implications. J Aff ect Disord 2006 ; 94 : 67-87
10. Lara DR , Akiskal HS. Toward an integrative model of the spectrum of mood, behavioral and personality disorders based on fear and anger traits: II. Implications for neurobiology, genetics and psychopharmacological treatment. J Aff ect Disord 2006 ; 94 : 89-103
11. Math SB , Janardhan Reddy YC. Issues in the pharmacological treatment of obsessive-compulsive disorder. Int J Clin Pract 2007 ; 61 : 1188-1197
12. Merikangas KR , Akiskal HS , A ngst J et a l. Lifetime and 12-month prevalence of bipolar spectrum in the National Comorbidity Survey replication. Arch Gen Psychiat 2007 ; 64 : 544-552
13. Sasson Y , Chopra M , Harrari E et al. Bipolar comorbidity: from diagnostic dilemmas to therapeutic challenge. Int J Neuropsychopharmacol 2003 ; 6 : 139-144
14. Simon NM , Otto MW , Wisniewski SR et al. Anxiety disorder comorbidity in bipolar disorder patients:data from the fi rst 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiat 2004 ; 161 : 2222-2229
15. Swartz CM , Shen WW. Is episodic obsessive compulsive disorder bipolar? A report of four cases. J Aff ect Disord 1999 ; 56 : 61-66
16. Zink M , Englisch S , Knopf U et al. Augmentation of clozapine with valproic acid for clozapine-induced obsessive-compulsive symptoms. Pharmacopsychiatry 2007 ; 40 : 1-2
17. Zutshi A , Kamath P , Reddy YC. Bipolar and nonbipolar obsessive-compulsive disorder: a clinical exploration. Compr Psychiat 2007 ; 48 : 245-251